{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:47:07Z","timestamp":1792226827095,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T00:00:00Z","timestamp":1362182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T00:00:00Z","timestamp":1362182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s40257-013-0011-2","type":"journal-article","created":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T14:05:10Z","timestamp":1362146710000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Management of Herpes Zoster and Post-Herpetic Neuralgia"],"prefix":"10.1007","volume":"14","author":[{"given":"Emily Yiping","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Ai Lian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Liang","family":"Tey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,2]]},"reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1212\/WNL.45.12_Suppl_8.S41","volume":"45","author":"MN Oxman","year":"1995","unstructured":"Oxman MN. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology. 1995;45:S41\u20136.","journal-title":"Neurology"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4065\/82.11.1341","volume":"82","author":"BP Yawn","year":"2007","unstructured":"Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction [published erratum appears in Mayo Clin Proc 2008;83:255]. Mayo Clin Proc. 2007;82:1341\u20139.","journal-title":"Mayo Clin Proc"},{"key":"11_CR3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","volume":"20","author":"RP Insinga","year":"2005","unstructured":"Insinga RP, Itzler RF, Pellissier JM, et al. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20:748\u201353.","journal-title":"J Gen Intern Med"},{"issue":"suppl 2","key":"11_CR4","first-page":"S2","volume":"109","author":"BA Weaver","year":"2009","unstructured":"Weaver BA. Herpes zoster overview: natural history and incidence. J Am Osteopath Assoc. 2009;109(suppl 2):S2\u20136.","journal-title":"J Am Osteopath Assoc"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1086\/598331","volume":"48","author":"JR McDonald","year":"2009","unstructured":"McDonald JR, Zeringue AL, Caplan L, et al. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis. 2009;48:1364\u201371.","journal-title":"Clin Infect Dis"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJMcp013211","volume":"347","author":"JW Gnann Jr","year":"2002","unstructured":"Gnann JW Jr, Whitley RJ. Herpes zoster. N Engl J Med. 2002;347:340\u20136.","journal-title":"N Engl J Med"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archinte.1982.00340150091017","volume":"142","author":"BL Burke","year":"1982","unstructured":"Burke BL, Steele RW, Beard OW, et al. Immune responses to varicella-zoster in the aged. Arch Intern Med. 1982;142:291\u20133.","journal-title":"Arch Intern Med"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1086\/320169","volume":"32","author":"K Schmader","year":"2001","unstructured":"Schmader K. Herpes zoster in older adults. Clin Infect Dis. 2001;32:1481\u20136.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"11_CR9","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1086\/514260","volume":"178","author":"RH Dworkin","year":"1998","unstructured":"Dworkin RH, Boon RJ, Griffin DR, et al. Postherpetic neuralgia: impact of famciclovir, age, rash, severity, and acute pain in herpes zoster patients. J Infect Dis. 1998;178(Suppl 1):S76\u201380.","journal-title":"J Infect Dis"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1067\/mjd.2002.120924","volume":"46","author":"EM Nagasako","year":"2002","unstructured":"Nagasako EM, Johnson RW, Griffin DR, et al. Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. J Am Acad Dermatol. 2002;46:834\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1086\/314562","volume":"179","author":"RJ Whitley","year":"1999","unstructured":"Whitley RJ, Weiss HL, Soong SJ, et al. Herpes zoster: risk categories for persistent pain. J Infect Dis. 1999;179:9\u201315.","journal-title":"J Infect Dis"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1212\/01.WNL.0000123261.00004.29","volume":"62","author":"BF Jung","year":"2004","unstructured":"Jung BF, Johnson RW, Griffin DR, et al. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology. 2004;62:1545\u201351.","journal-title":"Neurology"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/fampra\/19.5.471","volume":"19","author":"W Opstelten","year":"2002","unstructured":"Opstelten W, Mauritz JW, de Wit NJ, et al. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract. 2002;19:471\u20135.","journal-title":"Fam Pract"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","volume":"61","author":"MW Ragozzino","year":"1982","unstructured":"Ragozzino MW, Melton LJ 3rd, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61:310\u20136.","journal-title":"Medicine (Baltimore)"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/0002-9343(88)90366-X","volume":"85","author":"HH Balfour Jr","year":"1988","unstructured":"Balfour HH Jr. Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management. Am J Med. 1988;85:68\u201373.","journal-title":"Am J Med"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1503\/cmaj.091711","volume":"182","author":"M Drolet","year":"2010","unstructured":"Drolet M, Brisson M, Schmader KE, et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ. 2010;182:1731\u20136.","journal-title":"CMAJ"},{"key":"11_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1741-7015-8-37","volume":"8","author":"RW Johnson","year":"2010","unstructured":"Johnson RW, Bouhassira D, Kassianos G, et al. The impact of herpes zoster and post-herpetic neuralgia on quality of life. BMC Med. 2010;8:37.","journal-title":"BMC Med"},{"issue":"12 Suppl 8","key":"11_CR18","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1212\/WNL.45.12_Suppl_8.S56","volume":"45","author":"D Bowsher","year":"1995","unstructured":"Bowsher D. Pathophysiology of postherpetic neuralgia: towards a rational treatment. Neurology. 1995;45(12 Suppl 8):S56\u20137.","journal-title":"Neurology"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0304-3959(96)03122-3","volume":"67","author":"RH Dworkin","year":"1996","unstructured":"Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain. 1996;67:241\u201351.","journal-title":"Pain"},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(05)78359-8","volume":"351","author":"GD Schott","year":"1998","unstructured":"Schott GD. Triggering of delayed-onset postherpetic neuralgia. Lancet. 1998;351:419\u201320.","journal-title":"Lancet"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/BF01650204","volume":"14","author":"HW Doerr","year":"1987","unstructured":"Doerr HW, Rentschler M, Scheifler G. Serologic detection of active infections with human herpes viruses (CMV, EBV, HSV, VZV): diagnostic potential of IgA class and IgG subclass-specific antibodies. Infection. 1987;14:93\u20138.","journal-title":"Infection"},{"key":"11_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1386-6532(99)00042-6","volume":"14","author":"A Sauerbrei","year":"1999","unstructured":"Sauerbrei A, Eichhorn U, Schacke M, et al. Laboratory diagnosis of herpes zoster. J Clin Virol. 1999;14:31\u20136.","journal-title":"J Clin Virol"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.medmal.2011.11.001","volume":"42","author":"J Bruxelle","year":"2012","unstructured":"Bruxelle J, Pinchinat S. Effectiveness of antiviral treatment on acute phase of herpes zoster and development of post herpetic neuralgia: review of international publications. Med Mal Infect. 2012;42:53\u20138.","journal-title":"Med Mal Infect"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1001\/archinte.1997.00440290095010","volume":"157","author":"JL Jackson","year":"1997","unstructured":"Jackson JL, Gibbons R, Meyer G, et al. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia: a meta-analysis. Arch Intern Med. 1997;157:909\u201312.","journal-title":"Arch Intern Med"},{"key":"11_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.7326\/0003-4819-123-2-199507150-00002","volume":"123","author":"S Tyring","year":"1995","unstructured":"Tyring S, Barbarash RA, Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Ann Int Med. 1995;123:89\u201396.","journal-title":"Ann Int Med"},{"key":"11_CR26","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1128\/AAC.39.7.1546","volume":"39","author":"KR Beutner","year":"1995","unstructured":"Beutner KR, Friedman DJ, Forszpaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother. 1995;39:1546\u201353.","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR27","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1086\/510206","volume":"44","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007;44:S1\u201326.","journal-title":"Clin Infect Dis"},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/archfami.9.9.863","volume":"9","author":"SK Tyring","year":"2000","unstructured":"Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ. Antiviral therapy for herpes zoster: randomized controlled clinical trial of valacyclovir and famciclovir in immunocompetent patients 50\u00a0years and older. Arch Fam Med. 2000;9:863\u20139.","journal-title":"Arch Fam Med"},{"key":"11_CR29","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","volume":"17","author":"N Attal","year":"2010","unstructured":"Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17:1113\u201323.","journal-title":"Eur J Neurol"},{"key":"11_CR30","doi-asserted-by":"crossref","unstructured":"Khaliq W, Alam S, Puri N. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev 2007;(18):CD004846.","DOI":"10.1002\/14651858.CD004846.pub2"},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1371\/journal.pmed.0020164","volume":"2","author":"K Hempenstall","year":"2005","unstructured":"Hempenstall K, Nurmikko TJ, Johnson RW, et al. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med. 2005;2:e164.","journal-title":"PLoS Med"},{"key":"11_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1586\/ern.10.182","volume":"11","author":"M Wallace","year":"2011","unstructured":"Wallace M, Pappagallo M. Qutenza\u00ae: a capsaicin 8\u00a0% patch for the management of postherpetic neuralgia. Expert Rev Neurother. 2011;11:15\u201327.","journal-title":"Expert Rev Neurother"},{"key":"11_CR33","doi-asserted-by":"crossref","unstructured":"Derry S, Lloyd R, Moore RA, et al. Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2009;(7):CD007393.","DOI":"10.1002\/14651858.CD007393.pub2"},{"key":"11_CR34","doi-asserted-by":"crossref","unstructured":"Moore RA, Straube S, Wiffen PJ, et al. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 2009;(8):CD007076.","DOI":"10.1002\/14651858.CD007076.pub2"},{"key":"11_CR35","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jpain.2005.07.001","volume":"6","author":"MC Rowbotham","year":"2005","unstructured":"Rowbotham MC, Reisner LA, Davies PS, et al. Treatment response in antidepressant-na\u00efve postherpetic neuralgia patients: double-blind, randomized trial. J Pain. 2005;6:741\u20136.","journal-title":"J Pain"},{"key":"11_CR36","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","volume":"59","author":"SN Raja","year":"2002","unstructured":"Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002;59:1015\u201321.","journal-title":"Neurology"},{"key":"11_CR37","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1212\/WNL.41.7.1024","volume":"41","author":"MC Rowbotham","year":"1991","unstructured":"Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology. 1991;41:1024\u20138.","journal-title":"Neurology"},{"key":"11_CR38","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/WNL.50.6.1837","volume":"50","author":"CPN Watson","year":"1998","unstructured":"Watson CPN, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50:1837\u201341.","journal-title":"Neurology"},{"key":"11_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1200\/JCO.2004.03.172","volume":"22","author":"E Bruera","year":"2004","unstructured":"Bruera E, Palmer JL, Bosnjak S, et al. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. J Clin Oncol. 2004;22:185\u201392.","journal-title":"J Clin Oncol"},{"key":"11_CR40","doi-asserted-by":"crossref","unstructured":"Wiffen PJ, Derry S, Moore RA, et al. Carbamazepine for acute and chronic pain in adults. Cochrane Database Syst Rev 2011;(19):CD005451.","DOI":"10.1002\/14651858.CD005451.pub2"},{"key":"11_CR41","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","volume":"13","author":"N Attal","year":"2006","unstructured":"Attal N, Cruccu G, Haanpaa M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13:1153\u201369.","journal-title":"Eur J Neurol"},{"key":"11_CR42","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271\u201384.","journal-title":"N Engl J Med"},{"key":"11_CR43","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1001\/jama.2011.495","volume":"305","author":"R Voelker","year":"2011","unstructured":"Voelker R. FDA expands age range for shingles vaccine. JAMA. 2011;305:1526.","journal-title":"JAMA"},{"key":"11_CR44","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/cid\/cis638","volume":"55","author":"K Schmader","year":"2012","unstructured":"Schmader K, Oxman M, Levin M, et al. Persistence of the efficacy of zoster vaccine in the Shingles Prevention Study and the Short Term Persistence Substudy. Clin Infect Dis. 2012;55:1320\u20138.","journal-title":"Clin Infect Dis"},{"key":"11_CR45","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/archdermatol.2011.81","volume":"147","author":"W Lapolla","year":"2011","unstructured":"Lapolla W, DiGiorgio C, Haitz K, et al. Incidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes zoster. Arch Dermatol. 2011;147:901\u20137.","journal-title":"Arch Dermatol"},{"issue":"suppl 1","key":"11_CR46","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1086\/514274","volume":"178","author":"RJ Whitley","year":"1998","unstructured":"Whitley RJ, Shukla S, Crooks RJ. The identification of risk factors associated with persistent pain following herpes zoster. J Infect Dis. 1998;178(suppl 1):S71\u20135.","journal-title":"J Infect Dis"},{"key":"11_CR47","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0885-3924(97)00077-8","volume":"13","author":"D Bowsher","year":"1997","unstructured":"Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage. 1997;13:327\u201331.","journal-title":"J Pain Symptom Manage"},{"key":"11_CR48","first-page":"w13229","volume":"141","author":"M Kolsek","year":"2012","unstructured":"Kolsek M. TENS\u2014an alternative to antiviral drugs for acute herpes zoster treatment and postherpetic neuralgia prevention. Swiss Med Wkly. 2012;141:w13229.","journal-title":"Swiss Med Wkly"},{"key":"11_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/0019-5154.77551","volume":"56","author":"EE Nabarawy","year":"2011","unstructured":"Nabarawy EE. The use of narrow band ultraviolet light B in the prevention and treatment of postherpetic neuralgia (a pilot study). Indian J Dermatol. 2011;56:44\u20137.","journal-title":"Indian J Dermatol"},{"key":"11_CR50","doi-asserted-by":"crossref","unstructured":"Li Q, Chen N, Yang J, et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2011;(19):CD005451.","DOI":"10.1002\/14651858.CD007795.pub2"},{"key":"11_CR51","doi-asserted-by":"crossref","unstructured":"Chen N, Yang M, He L, et al. Corticosteroids for preventing post-herpetic neuralgia. Cochrane Database Syst Rev 2010;(8):CD005582.","DOI":"10.1002\/14651858.CD005582.pub3"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-013-0011-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-013-0011-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-013-0011-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-013-0011-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T09:46:36Z","timestamp":1659087996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-013-0011-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s40257-013-0011-2","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,2]]},"assertion":[{"value":"2 March 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}